UBS Lowers Lam Research Price Target to $425
- Rating
- Buy
- Target
- $425
- from $435 (−2%)
- Upside
- +61%
- LRCX at $263 today

What the analyst said
UBS analyst Timothy Arcuri lowered the price target on Lam Research (NASDAQ: LRCX) to $425 (from $435) while maintaining a Buy rating on September 1, 2026.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
LRCX trades at $263. The 7 analysts who set a target in the last 3 months range from $338 to $425, with a median of $367. This $425 target is 16% above the median, the highest on the Street.
Since the note LRCX has moved −13% (from $301). 12-month window: day 49 of 365, closes on September 1, 2027.
Track record
This callOpen: LRCX has not reached $425 yet. This 12-month target is scored on September 1, 2027.
Firm track recordUBS: 83% of its 30 targets at least a year old were reached within 12 months (#15 of 28 firms). Accuracy ranking →
UBS on Lam Research
UBS price targets on Lam Research
7 calls from January 20, 2026 to September 1, 2026. The target went from $255 to $425 (+67%). The rating stayed Buy.
- September 1, 2026 This noteTarget cut from $435 (−2%)Buy$425
- July 15, 2026Target raised from $375 (+16%)Buy$435
- June 9, 2026Target raised from $310 (+21%)Buy$375
- April 23, 2026Kept the $310 targetBuy$310
- April 13, 2026Target raised from $275 (+13%)Buy$310
- January 29, 2026Target raised from $255 (+8%)Buy$275
- January 20, 2026Earliest call shownBuy$255



